Aptamer Sciences Inc (KOSDAQ:291650)
South Korea flag South Korea · Delayed Price · Currency is KRW
891.00
-1.00 (-0.11%)
At close: Jun 5, 2026

Aptamer Sciences Revenue

In the year 2024, Aptamer Sciences had annual revenue of 1.08B KRW with 345.26% growth. Aptamer Sciences had revenue of 920.07M in the quarter ending December 31, 2024, with 5,471.58% growth.

Revenue
1.08B
Revenue Growth
+281.58%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
54.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.08B839.63M345.26%
Dec 31, 2023243.19M-115.07M-32.12%
Dec 31, 2022358.25M88.98M33.04%
Dec 31, 2021269.28M40.77M17.84%
Dec 31, 2020228.51M-179.09M-43.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Psomagen60.70B
J2KBIO36.82B
PanGen Biotech13.71B
ADBiotech12.51B
HLB Pep5.52B
EyeGene4.02B
Quratis1.26B
Progen450.00M
Revenue Rankings